Clinical Trial Update: HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Fluticasone Furoate/Vilanterol in adults and adolescents with asthma; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• BREO ELLIPTA (fluticasone furoate and vilanterol trifenatate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-09-05